| __timestamp | Lantheus Holdings, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 125519000 | 1256834000000 |
| Thursday, January 1, 2015 | 135522000 | 1271973000000 |
| Friday, January 1, 2016 | 137780000 | 1173296000000 |
| Sunday, January 1, 2017 | 162135000 | 1274610000000 |
| Monday, January 1, 2018 | 174885000 | 1437534000000 |
| Tuesday, January 1, 2019 | 174811000 | 2201424000000 |
| Wednesday, January 1, 2020 | 138761000 | 2203504000000 |
| Friday, January 1, 2021 | 187695000 | 2462160000000 |
| Saturday, January 1, 2022 | 581703000 | 2783406000000 |
| Sunday, January 1, 2023 | 709543000 | 2832257000000 |
| Monday, January 1, 2024 | 2832257000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical landscape, Takeda Pharmaceutical Company Limited and Lantheus Holdings, Inc. present a fascinating study in contrasts. Over the past decade, Takeda has consistently demonstrated robust growth, with its gross profit soaring from approximately 1.26 trillion in 2014 to an impressive 2.83 trillion by 2023. This represents a remarkable 125% increase, underscoring Takeda's dominance in the global market.
Conversely, Lantheus Holdings, Inc. has shown a more modest trajectory. Starting at 125 million in 2014, its gross profit reached 709 million by 2023, marking a significant 467% growth. While Lantheus's figures are dwarfed by Takeda's, its growth rate is noteworthy, reflecting its strategic positioning in niche markets.
The data for 2024 remains incomplete, leaving room for speculation on future trends. As these companies navigate the complexities of the pharmaceutical industry, their financial journeys offer valuable insights into market dynamics and strategic growth.
Bristol-Myers Squibb Company and Takeda Pharmaceutical Company Limited: A Detailed Gross Profit Analysis
Takeda Pharmaceutical Company Limited and Incyte Corporation: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Takeda Pharmaceutical Company Limited vs Walgreens Boots Alliance, Inc.
Takeda Pharmaceutical Company Limited vs Grifols, S.A.: A Gross Profit Performance Breakdown
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs Lantheus Holdings, Inc.
Who Generates Higher Gross Profit? Takeda Pharmaceutical Company Limited or Arrowhead Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited vs Vericel Corporation: A Gross Profit Performance Breakdown
Takeda Pharmaceutical Company Limited vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Takeda Pharmaceutical Company Limited and Amphastar Pharmaceuticals, Inc. Trends
Genmab A/S and Lantheus Holdings, Inc.: A Detailed Gross Profit Analysis
Incyte Corporation vs Lantheus Holdings, Inc.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Lantheus Holdings, Inc. vs Amneal Pharmaceuticals, Inc.